Novel stabilizer of 14-3-3 PPIs, Diastereoepimer of aminopeptidase inhibitor bestatin

Second-generation antihistamine and mast cell stabilizer, being highly selective for the H1 receptor

The precursor of the nocardicins

Mucolytic and bronchospasm relieving agent

Novel inhibitor of extracellular polymeric substances (EPS)

Potent, selective, high efficacy 5-HT1A receptor agonist

Inactive isomer of EPZ005687 and can be used as the negative control for EPZ005687

Novel selective SMYD3 inhibitor

Novel selective SMYD2 inhibitor

Novel SMYD2 inhibitor

Novel Oral Selective Estrogen Receptor Degrader with Highly Improved Antitumor Effect and Favorable Druggability

Selective squalene synthase (SQS) inhibitor

Retinoic acid receptor (RAR) subtype α-selective agonist

Novel Selective ERAP1 Inhibitor

Novel competitive inhibitor of ERAP1 aminopeptidase activity

Novel ErbB type I receptor tyrosine kinase inhibitor for the treatment of hyperproliferative diseases

Novel potent inhibitor of ERCC1-XPF activity, targeting DNA repair in tumor cells

Natural Nsp15 inhibitor against SARS-COV2

Novel ATP-competitive Selective c-Jun N-terminal kinase (JNK) inhibitor

Analogue of the lipid A portion of the endotoxin lipopolysaccharide (LPS) with potential immunomodulating activity, binding to the Toll-like receptor (TLR)/CD14/MD2 receptor complex, inhibiting the activation of the receptor complex by LPS

Negative control for ERK Inhibitor II AOB6420

Novel degrader of ERK1/2, eliciting downregulation of phospho-ERK1/2 signal.